• Avantor expanded its Masterflex fluid handling portfolio, focusing on interoperable and scalable bioprocessing solutions for life sciences customers.
• The company highlighted these Masterflex upgrades at INTERPHEX 2026, using the industry event to showcase operational integration and bioprocessing capabilities.
• These product moves come alongside leadership changes and early signs of business stabilization in certain segments.

For investors watching NYSE:AVTR, the product work around Masterflex arrives after a difficult share price run. The stock trades at $7.96, with a 30.5% decline year to date, a 38.2% decline over the past year, and a 60.3% decline across three years. Against that backdrop, tangible product and operational changes…